Given the increased reporting of multi-resistant bacteria and the shortage of newly approved medicines, researchers have been looking towards extreme and unusual environments as a new source of antibiotics. Streptomyces currently provides many of the world’s clinical antibiotics, so it comes as no surprise that these bacteria have recently been isolated from traditional medicine. Given the wide array of traditional medicines, it is hoped that these discoveries can provide the much sought after core structure diversity that will be required of a new generation of antibiotics. This review discusses the contribution of Streptomyces to antibiotics and the potential of newly discovered species in traditional medicine. We also explore how knowledge of traditional medicines can aid current initiatives in sourcing new and chemically diverse antibiotics.
Bibliographical noteFunding Information:
We acknowledge the help of Dr Du?ica Vujaklija, who took time to read over this article and make helpful suggestions.
© 2020 Microbiology Society. All rights reserved.
Copyright 2020 Elsevier B.V., All rights reserved.
- extreme environment
- secondery metabolites
- silent gene clusters